WVE Stock Analysis: Buy, Sell, or Hold?
WVE - Wave Life Sciences Ltd. Ordinary Shares
$4.67
-0.14 (-2.91%)
▼
5d:
-4.3%
30d:
-7.43%
90d:
-17.49%
WAIT
LOW Confidence
Analysis Updated: Sep 10, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 2, 2026 at $4.88 · last confirmed Sep 9, 2026
Strength: 8.1/10
Get Alerted When WVE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: WVE shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: WVE shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: WVE is currently trading at $4.67, which is considered oversold relative to its 30-day fair value range of $4.85 to $5.69.
Technical Outlook: Technically, WVE is in a strong downtrend. The price is currently testing key support at $4.63. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $19.06 (+308.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, WVE is in a strong downtrend. The price is currently testing key support at $4.63. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $19.06 (+308.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.85 -
$5.69
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Protect Your Profits
Holding WVE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 308.2% below Wall St target ($19.06)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.85 -
$5.69
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$4.63
Resistance Level
$5.28
Current Trend
Strong Downtrend
Technical data as of
Sep 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.92
Wall Street Target
$19.06
(+308.2%)
Revenue Growth (YoY)
-73.9%
Share & Embed Analysis
Last updated: September 11, 2026 9:15 AM ET
Data refreshes hourly during market hours. Next update: 10:15 AM
Data refreshes hourly during market hours. Next update: 10:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WVE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$88 | 48 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$55 | 45 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 54 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 43 HOLD |
Advanced WVE Option Strategies
Professional options setups generated by AI based on today's WVE price and gamma walls.